The company announces that interim CFO is stepping down
New CFO expected within six months
Move should be seen in light of possible international listing...
…and increased focus on international capital markets and growth
07 Feb 2021
New CFO and possible international listing
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
New CFO and possible international listing
Nykode Therapeutics ASA (NYKD:OSL) | 0 0 0.0%
- Published:
07 Feb 2021 -
Author:
Lars Mørland Knudsen -
Pages:
6 -
The company announces that interim CFO is stepping down
New CFO expected within six months
Move should be seen in light of possible international listing...
…and increased focus on international capital markets and growth